Učitavanje...
Treatment of Newly Diagnosed Myeloma: Bortezomib-based Triplet
In this paper we review the options for the treatment of newly diagnosed myeloma in a patient who is a candidate for autologous stem cell transplantation. Bortezomib, lenalidomide, dexamethasone (VRD) has been studied in two randomized trials as first line therapy. In one of these trials, VRD demons...
Spremljeno u:
| Izdano u: | Semin Oncol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5266536/ https://ncbi.nlm.nih.gov/pubmed/28061990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminoncol.2016.11.003 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|